IP Verse

Arrowhouse competitive analysis

Explore patent oppositions filed by Arrowhouse against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026

Patent Number	Title	Applicant	Opposition Date
EP3519825	Improved Methods Of Assessing Gfap Status In Patient Samples	ABBOTT LABORATORIES	Jun 26, 2026
EP4037735	Drug Delivery Device	AMGEN	Jun 2, 2026
EP3407884	Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1	MEMORIAL SLOAN KETTERING CANCER CENTER	Apr 9, 2026
EP3343726	Vehicle Charging Points Infrastructure Management System	ATOS FRANCE	Jan 22, 2026
EP4064852	Mushroom-Based Food Product	FABLE	Nov 12, 2025
EP4096717	Treatment Of Cancer	INNATE PHARMA	Sep 10, 2025
EP4226941	Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna	GLAXOSMITHKLINE	Jul 23, 2025
EP4241767	Novel Lipids And Compositions For The Delivery Of Therapeutics	ARBUTUS BIOPHARMA	Jul 23, 2025
EP3681266	Methods Of Agricultural Production Of Brassica Carinata Oilseed Crop	NUSEED INNOVATION	Jul 22, 2025
EP3483219	Transparent Plastic Substrate And Plastic Lens	HOYA LENS THAILAND	May 14, 2025

Discover the latest PTAB cases involving Arrowhouse, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Arrowhouse with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
ARROWHOUSE	12	-	-	-
ABBOTT LABORATORIES	24	46	13	1
AMGEN	9	146	8	11
ARBUTUS BIOPHARMA	-	7	-	3